CBD Life Sciences Inc. Announces LOI with New Jersey Dispensary to Expand Market Presence

Reuters09-23

<a href="https://laohu8.com/S/CBDL">CBD Life Sciences Inc.</a> Announces LOI with <a href="https://laohu8.com/S/NJR">New Jersey</a> Dispensary to Expand Market Presence

CBD Life Sciences Inc. has announced a Letter of Intent (LOI) with a licensed dispensary in New Jersey, marking a significant expansion into the East Coast cannabis market. The agreement involves a dual-channel partnership where CBDL's products, such as CBD Pain Relief Cream and Delta-8 Gummies, will be featured in the New Jersey dispensary. In exchange, select products from the dispensary will be stocked in CBDL's retail locations. This collaboration aims to increase brand recognition, enhance retail distribution, and create new revenue streams, with management anticipating seven-figure annualized revenues. The partnership is part of CBDL's strategy to expand its market presence across the East Coast.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cbd Life Sciences Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1076821) on September 23, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2569794684?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-23 19:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569794684","market":"fut","top_or_hot":-1,"title":"CBD Life Sciences Inc. Announces LOI with New Jersey Dispensary to Expand Market Presence","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/CBDL\">CBD Life Sciences Inc.</a> Announces LOI with <a href=\"https://laohu8.com/S/NJR\">New Jersey</a> Dispensary to Expand Market Presence\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/CBDLD\">CBD Life Sciences Inc.</a> has announced a Letter of Intent (LOI) with a licensed dispensary in New Jersey, marking a significant expansion into the East Coast cannabis market. The agreement involves a dual-channel partnership where CBDL's products, such as CBD Pain Relief Cream and Delta-8 Gummies, will be featured in the New Jersey dispensary. In exchange, select products from the dispensary will be stocked in CBDL's retail locations. This collaboration aims to increase brand recognition, enhance retail distribution, and create new revenue streams, with management anticipating seven-figure annualized revenues. The partnership is part of CBDL's strategy to expand its market presence across the East Coast.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cbd Life Sciences Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1076821) on September 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CBD Life Sciences Inc. Announces LOI with New Jersey Dispensary to Expand Market Presence</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCBD Life Sciences Inc. Announces LOI with New Jersey Dispensary to Expand Market Presence\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-23 19:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/CBDL\">CBD Life Sciences Inc.</a> Announces LOI with <a href=\"https://laohu8.com/S/NJR\">New Jersey</a> Dispensary to Expand Market Presence\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/CBDLD\">CBD Life Sciences Inc.</a> has announced a Letter of Intent (LOI) with a licensed dispensary in New Jersey, marking a significant expansion into the East Coast cannabis market. The agreement involves a dual-channel partnership where CBDL's products, such as CBD Pain Relief Cream and Delta-8 Gummies, will be featured in the New Jersey dispensary. In exchange, select products from the dispensary will be stocked in CBDL's retail locations. This collaboration aims to increase brand recognition, enhance retail distribution, and create new revenue streams, with management anticipating seven-figure annualized revenues. The partnership is part of CBDL's strategy to expand its market presence across the East Coast.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cbd Life Sciences Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1076821) on September 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CBDL","symbol_name":"CBD Life Sciences Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL9b7HqN:1","article_id":"2569794684","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569794684","pubTimestamp":1758625259,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"CBD Life Sciences Inc. has announced a Letter of Intent  with a licensed dispensary in New Jersey, marking a significant expansion into the East Coast cannabis market. The agreement involves a dual-channel partnership where CBDL's products, such as CBD Pain Relief Cream and Delta-8 Gummies, will be featured in the New Jersey dispensary. In exchange, select products from the dispensary will be stocked in CBDL's retail locations. This collaboration aims to increase brand recognition, enhance retail distribution, and create new revenue streams, with management anticipating seven-figure annualized revenues. The partnership is part of CBDL's strategy to expand its market presence across the East Coast.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CBDL":"CBD Life Sciences Inc."},"translate_title":"CBD Life Sciences Inc.宣布与新泽西州药房签订意向书以扩大市场份额","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CBDL":0.9},"content_text":"CBD Life Sciences Inc. Announces LOI with New Jersey Dispensary to Expand Market Presence\n    \n\nCBD Life Sciences Inc. has announced a Letter of Intent (LOI) with a licensed dispensary in New Jersey, marking a significant expansion into the East Coast cannabis market. The agreement involves a dual-channel partnership where CBDL's products, such as CBD Pain Relief Cream and Delta-8 Gummies, will be featured in the New Jersey dispensary. In exchange, select products from the dispensary will be stocked in CBDL's retail locations. This collaboration aims to increase brand recognition, enhance retail distribution, and create new revenue streams, with management anticipating seven-figure annualized revenues. The partnership is part of CBDL's strategy to expand its market presence across the East Coast.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cbd Life Sciences Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1076821) on September 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2569794684","isCrawlerRequest":true}